Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

McMaster University

$99,131.00

Placenta on a chip: A humanized platform for testing of pharmaceuticals and environmental chemicals

EF 2018-19

Résumé
The human placenta is a complex organ that controls the health of the baby and also impacts*the health of the mother. Signals from the cells that form the barrier between mother and fetus*can program the babies health after it is born or control whether the baby is born*prematurely. 1 in 9 babies are born prematurely and this can lead to many health problems in*later life. It is difficult to study this barrier in animal models or humans because of the*complexity of the placenta. Our research will develop a placenta on a chip; a micro-device*that mimics a small section of the human placenta in 3D. We will develop special surfaces*that allow the stem cells of the placenta to behave as though they were in their natural*environment within the womb. This portable placenta will be the first example of such a*device that brings together the important cells of the placenta and simulates the proper*oxygen levels and blood flow that would exist in the human placenta. This device will be very*useful in reducing the cost of testing drugs to see if they would be harmful to the mother or*fetus and also help to reduce the number of animals that are used in drug testing. Importantly,*we will also verify whether this device predicts the biological responses of actual placental*tissues when treated with environmental toxins; something that no one has evaluated. We will*easily and inexpensively be able to identify whether certain chemicals are causing the*maternal-fetal barrier to release signals that might harm the baby or cause premature birth.*We have already partnered with Evik Diagnostics, a Canadian company that is interested in*diagnostic testing for conditions that affect the health of the mother and baby in pregnancy.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
523792-2018
Name nom
Raha, Sandeep
Department département
McMaster Children and Youth University
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
99131
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Placenta on a chip: A humanized platform for testing of pharmaceuticals and environmental chemicals
Keyword
NSERC
Application summary
The human placenta is a complex organ that controls the health of the baby and also impacts*the health of the mother. Signals from the cells that form the barrier between mother and fetus*can program the babies health after it is born or control whether the baby is born*prematurely. 1 in 9 babies are born prematurely and this can lead to many health problems in*later life. It is difficult to study this barrier in animal models or humans because of the*complexity of the placenta. Our research will develop a placenta on a chip; a micro-device*that mimics a small section of the human placenta in 3D. We will develop special surfaces*that allow the stem cells of the placenta to behave as though they were in their natural*environment within the womb. This portable placenta will be the first example of such a*device that brings together the important cells of the placenta and simulates the proper*oxygen levels and blood flow that would exist in the human placenta. This device will be very*useful in reducing the cost of testing drugs to see if they would be harmful to the mother or*fetus and also help to reduce the number of animals that are used in drug testing. Importantly,*we will also verify whether this device predicts the biological responses of actual placental*tissues when treated with environmental toxins; something that no one has evaluated. We will*easily and inexpensively be able to identify whether certain chemicals are causing the*maternal-fetal barrier to release signals that might harm the baby or cause premature birth.*We have already partnered with Evik Diagnostics, a Canadian company that is interested in*diagnostic testing for conditions that affect the health of the mother and baby in pregnancy.